243 related articles for article (PubMed ID: 34636718)
1. A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma.
Wu G; Xu Y; Zhang H; Ruan Z; Zhang P; Wang Z; Gao H; Che X; Xia Q; Chen F
Bioengineered; 2021 Dec; 12(1):7805-7819. PubMed ID: 34636718
[TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
4. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
5. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
Sun Y; Xu Y; Che X; Wu G
Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
[TBL] [Abstract][Full Text] [Related]
6. Autophagy-related gene
Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
8. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
9. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract][Full Text] [Related]
10. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
11. A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma.
Liu M; Pan Q; Xiao R; Yu Y; Lu W; Wang L
Sci Rep; 2020 Jul; 10(1):12949. PubMed ID: 32737333
[TBL] [Abstract][Full Text] [Related]
12. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
14. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
Tang W; Cao Y; Ma X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
[TBL] [Abstract][Full Text] [Related]
15. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.
Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q
Front Genet; 2022; 13():862210. PubMed ID: 35903358
[No Abstract] [Full Text] [Related]
16. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
17. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Guo X; Sun Z; Jiang S; Jin X; Wang H
Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951
[TBL] [Abstract][Full Text] [Related]
18. The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma.
Xie D; Wang S; Jiang B; Li G; Wu G
Aging (Albany NY); 2024 Jan; 16(1):246-266. PubMed ID: 38180750
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
[TBL] [Abstract][Full Text] [Related]
20. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]